Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Immediate and long-term effects of addition of exercise to a 16-week very low calorie diet on low-grade inflammation in obese, insulin-dependent type 2 diabetic patients.

Snel M, van Diepen JA, Stijnen T, Pijl H, Romijn JA, Meinders AE, Voshol P, Jazet IM.

Food Chem Toxicol. 2011 Dec;49(12):3104-11. doi: 10.1016/j.fct.2011.09.032.

PMID:
22001172
2.

Quality of life in type 2 diabetes mellitus after a very low calorie diet and exercise.

Snel M, Sleddering MA, Vd Peijl ID, Romijn JA, Pijl H, Meinders AE, Jazet IM.

Eur J Intern Med. 2012 Mar;23(2):143-9. doi: 10.1016/j.ejim.2011.07.004.

PMID:
22284244
3.

Long-term beneficial effect of a 16-week very low calorie diet on pericardial fat in obese type 2 diabetes mellitus patients.

Snel M, Jonker JT, Hammer S, Kerpershoek G, Lamb HJ, Meinders AE, Pijl H, de Roos A, Romijn JA, Smit JW, Jazet IM.

Obesity (Silver Spring). 2012 Aug;20(8):1572-6. doi: 10.1038/oby.2011.390.

4.

Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects.

Wing RR, Marcus MD, Salata R, Epstein LH, Miaskiewicz S, Blair EH.

Arch Intern Med. 1991 Jul;151(7):1334-40.

PMID:
2064484
5.
7.

Effects of adding exercise to a 16-week very low-calorie diet in obese, insulin-dependent type 2 diabetes mellitus patients.

Snel M, Gastaldelli A, Ouwens DM, Hesselink MK, Schaart G, Buzzigoli E, Frölich M, Romijn JA, Pijl H, Meinders AE, Jazet IM.

J Clin Endocrinol Metab. 2012 Jul;97(7):2512-20. doi: 10.1210/jc.2011-3178.

PMID:
22569236
9.

The effect of very-low-calorie diet on mRNA expression of inflammation-related genes in subcutaneous adipose tissue and peripheral monocytes of obese patients with type 2 diabetes mellitus.

Mraz M, Lacinova Z, Drapalova J, Haluzikova D, Horinek A, Matoulek M, Trachta P, Kavalkova P, Svacina S, Haluzik M.

J Clin Endocrinol Metab. 2011 Apr;96(4):E606-13. doi: 10.1210/jc.2010-1858.

PMID:
21289263
10.

Very-low-calorie diet: a quick therapeutic tool to improve β cell function in morbidly obese patients with type 2 diabetes.

Malandrucco I, Pasqualetti P, Giordani I, Manfellotto D, De Marco F, Alegiani F, Sidoti AM, Picconi F, Di Flaviani A, Frajese G, Bonadonna RC, Frontoni S.

Am J Clin Nutr. 2012 Mar;95(3):609-13. doi: 10.3945/ajcn.111.023697.

11.

Very low calorie diet (VLCD): a useful alternative in the treatment of the obese NIDDM patient.

Capstick F, Brooks BA, Burns CM, Zilkens RR, Steinbeck KS, Yue DK.

Diabetes Res Clin Pract. 1997 May;36(2):105-11.

PMID:
9229194
12.

Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function.

Hammer S, Snel M, Lamb HJ, Jazet IM, van der Meer RW, Pijl H, Meinders EA, Romijn JA, de Roos A, Smit JW.

J Am Coll Cardiol. 2008 Sep 16;52(12):1006-12. doi: 10.1016/j.jacc.2008.04.068.

13.
14.

Five year results of a prospective very low calorie diet or conventional weight loss programme in type 2 diabetes.

Paisey RB, Frost J, Harvey P, Paisey A, Bower L, Paisey RM, Taylor P, Belka I.

J Hum Nutr Diet. 2002 Apr;15(2):121-7.

PMID:
11972741
15.

Calorie restriction is a major determinant of the short-term metabolic effects of gastric bypass surgery in obese type 2 diabetic patients.

Lips MA, de Groot GH, van Klinken JB, Aarts E, Berends FJ, Janssen IM, Van Ramshorst B, Van Wagensveld BA, Swank DJ, Van Dielen F, Willems van Dijk K, Pijl H.

Clin Endocrinol (Oxf). 2014 Jun;80(6):834-42. doi: 10.1111/cen.12254.

PMID:
23711328
16.

An exercise intervention without weight loss decreases circulating interleukin-6 in lean and obese men with and without type 2 diabetes mellitus.

Dekker MJ, Lee S, Hudson R, Kilpatrick K, Graham TE, Ross R, Robinson LE.

Metabolism. 2007 Mar;56(3):332-8.

PMID:
17292721
17.
18.
19.

Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet.

Dostálová I, Roubícek T, Bártlová M, Mráz M, Lacinová Z, Haluzíková D, Kaválková P, Matoulek M, Kasalicky M, Haluzík M.

Eur J Endocrinol. 2009 Sep;161(3):397-404. doi: 10.1530/EJE-09-0417.

20.

Subcutaneous adipose tissue cytokine production is not responsible for the restoration of systemic inflammation markers during weight loss.

Salas-Salvadó J, Bulló M, García-Lorda P, Figueredo R, Del Castillo D, Bonada A, Balanzà R.

Int J Obes (Lond). 2006 Dec;30(12):1714-20.

PMID:
16652132

Supplemental Content

Support Center